Cigna Group $CI Shares Bought by Wilsey Asset Management Inc.

Wilsey Asset Management Inc. grew its stake in shares of Cigna Group (NYSE:CIFree Report) by 2.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 123,645 shares of the health services provider’s stock after purchasing an additional 2,601 shares during the period. Cigna Group makes up about 5.0% of Wilsey Asset Management Inc.’s holdings, making the stock its 12th largest position. Wilsey Asset Management Inc.’s holdings in Cigna Group were worth $34,086,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC increased its stake in Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares in the last quarter. NewEdge Advisors LLC raised its holdings in Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after purchasing an additional 958 shares during the last quarter. Treasurer of the State of North Carolina raised its holdings in Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after purchasing an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. purchased a new stake in Cigna Group during the second quarter worth $163,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 222,213 shares of company stock worth $64,751,950 over the last quarter. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Performance

Cigna Group stock opened at $275.26 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The company has a market capitalization of $72.73 billion, a price-to-earnings ratio of 11.39, a PEG ratio of 0.93 and a beta of 0.29. The stock has a fifty day moving average of $285.90 and a two-hundred day moving average of $281.20. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CI. Sanford C. Bernstein raised their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Royal Bank Of Canada boosted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Wells Fargo & Company increased their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $336.00 to $307.00 in a research report on Tuesday. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Check Out Our Latest Stock Analysis on Cigna Group

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.